Etoricoxib Intermediate Market a CAGR of 4.5% during the forecast period of 2025 to 2032. Introduction
The Etoricoxib Intermediate Market plays a critical role within the global pharmaceutical supply chain, supporting the production of etoricoxib, a widely prescribed selective COX-2 inhibitor used in the treatment of pain, inflammation, osteoarthritis, rheumatoid arthritis, and gout. As demand for effective non-steroidal anti-inflammatory drugs continues to rise, the...
0 Megosztás
457 Nézettség